IGHE and allergic disease: As a consequence, the FDA in the United States and the Paul Ehrlich Institute in Germany have categorized vaccination with plasmid DNA as gene therapy.21 Also allergy‐specific concerns have been raised; primarily that uncontrolled expression of natural allergens could potentially cause adverse events by cross‐linking of preexisting IgE.